Search - tctmd.com

Displaying 861 - 880 of 1574

Sort: Relevancy | Date

Presentation TCT 2017

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella

November 01, 2017

Presentation TCT 2017

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Presenter: Gary M. Ansel, Sahil A. Parikh, Andrew J. Klein

November 01, 2017

Presentation TCT 2017

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Presenter: Bernard R. Chevalier, Corrado Tamburino, Kai Xu

October 31, 2017

Presentation TCT 2017

Renal Denervation Trial Design Considerations: Challenges and Lessons Learned

Presenter: Hiren Mistry, Michael A. Weber, Michael Böhm

October 31, 2017

Presentation TCT 2017

Updates From the U.S. REFLECT Clinical Trial

Presenter: Tamim Nazif

October 31, 2017

Presentation TCT 2017

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

Presenter: Joachim Schofer

October 31, 2017

Presentation TCT 2017

Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned

Presenter: David E. Kandzari, Jaime Raben

October 31, 2017

Presentation TCT 2017

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Samir R. Kapadia

October 31, 2017

Presentation TCT 2017

Current State of Thoracic Branch Devices and Ongoing Clinical Trials

Presenter: Brian G. DeRubertis, Peter A. Schneider, Hiroo Takayama

October 31, 2017

Presentation TCT 2017

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra

October 31, 2017

Presentation TCT 2017

TAP vs Culotte Stenting Beyond The Clinical Trials: A Different View

Presenter: Cihangir Kaymaz, Jeroen Vos, Armando Perez de Prado

October 31, 2017

Presentation TCT 2017

Representation of Women and Minorities in European Trials

Presenter: David P. Faxon, Cindy L. Grines, Angeles Alonso Garcia

October 31, 2017

Presentation TCT 2017

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne

October 31, 2017

Presentation TCT 2017

The Potential For BRS: What Weve Learned From Pushing The Envelope

Presenter: Stephen G. Ellis, Takeshi Kimura, Corrado Tamburino

October 31, 2017

Presentation TCT 2017

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran

October 31, 2017

Presentation TCT 2017

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB SCAAR

Presenter: Stephen G. Ellis, Takeshi Kimura, Stefan K. James

October 31, 2017

Presentation TCT 2017

Registry Update: BVS STEMI STRATEGY

Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi

October 31, 2017

Presentation TCT 2017

Registry Update: IT-DISAPPEARS

Presenter: Stephen G. Ellis, Takeshi Kimura, Francesco Bedogni

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Diversity in Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Christopher J Popma

October 31, 2017

Advertisement

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Renal Denervation Trial Design Considerations: Challenges and Lessons Learned

Updates From the U.S. REFLECT Clinical Trial

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Current State of Thoracic Branch Devices and Ongoing Clinical Trials

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

TAP vs Culotte Stenting Beyond The Clinical Trials: A Different View

Representation of Women and Minorities in European Trials

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

The Potential For BRS: What Weve Learned From Pushing The Envelope

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Registry Update: ABSORB SCAAR

Registry Update: BVS STEMI STRATEGY

Registry Update: IT-DISAPPEARS

FDA Perspectives on Diversity in Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content